Medical/Pharmaceuticals
Novaliq Announces More than 50% Patients Enrolled in CyclASol® Phase 3 Dry Eye Disease Trial ESSENCE-2
- Topline results expected in 2nd half 2021; 475 out of a 834 target patients randomized in ESSENCE-2 - Enrollment for 12-month safety extension trial (ESSENCE-2 OLE) completed - Phase 2B/3 Trial ESSENCE-1 Published in Cornea: The Journal of Cornea and External Disease HEIDELBERG, Germany and C...
2021-04-28 20:00
1903
CROs dMed and Clinipace Merge to Accelerate Customer Success
SHANGHAI and MORRISVILLE, N.C., April 28, 2021 /PRNewswire/ -- dMed Global, a full-service Clinical Contract Research Organization (CRO) based inShanghai, China, and Clinipace Incorporated, a full-service Clinical CRO with headquarters inNorth Carolina, USA, announced today that the two companies...
2021-04-28 20:00
3794
I-Mab Filed 2020 Annual Report on Form 20-F
SHANGHAI and GAITHERSBURG, Md., April 28, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that the Company has filed its annual report on Form 20...
2021-04-28 20:00
2004
ERT and Bioclinica Close Merger, Creating the Global Leader in Clinical Trial Endpoint Technology
PHILADELPHIA, April 28, 2021 /PRNewswire/ -- ERT, a global leader in clinical endpoint data solutions, today announced the close of its merger withBioclinica , a technological and scientific leader in clinical imaging. This combination creates the global leader in clinical trial endpoint technolog...
2021-04-28 19:59
3102
Turn Biotechnologies completes latest round of funding
Silicon Valley investor Khosla Ventures joins esteemed group of global investors backing Turn MOUNTAIN VIEW, Calif., April 28, 2021 /PRNewswire/ -- Turn Biotechnologies, a company developing novel RNA medicines for untreatable age-related conditions, today announced that it has closed its latest...
2021-04-28 19:50
3573
Samsung Biologics Reports First Quarter 2021 Financial Results
* Q1'21 revenue of KRW 260.8 billion increased 26% compared to Q1'20. * Q1'21 operating profit of KRW 74.3 billion increased 19% compared to Q1'20. * Q1'21 operating margin held steady at 28%. * All manufacturing facilities remain fully operational, without any disruptions caused by the COV...
2021-04-28 16:37
4832
Ascensia Rolls Out The On@Pro Online Educational Platform for Healthcare Professionals in Collaboration With the Tumaini Institute
BASEL, Switzerland, April 28, 2021 /PRNewswire/ -- Ascensia Diabetes Care, a leading global diabetes care company, has announced today that it has rolled out an online educational platform for continuous personal learning aimed at healthcare professionals working with people with diabetes. The On...
2021-04-28 15:00
1935
New Distribution Facility Expands Bushu Pharma's Gateway to Asia (GTA) Services
KAWAGOE, Japan, April 28, 2021 /PRNewswire/ -- Bushu Pharmaceuticals Ltd. (hereinafter "Bushu Pharma") has established the Bushu Pharma Kazo Packaging Center located within the Kazo Pharmaceuticals Joint Distribution Center of Chuo Unyu Company ("Chuo Unyu") to carry out inspection, labeling, pac...
2021-04-28 14:00
1421
Genesis MedTech to Introduce Revolutionary Laparoscopic Technology to China and Singapore
SINGAPORE, April 28, 2021 /PRNewswire/ -- Genesis MedTech has entered a strategic distribution agreement with LivsMed, a medical device company that brings ground-breaking technology to minimally invasive surgery, for the sales and distribution of the ArtiSential™ line of products for the Chin...
2021-04-28 10:01
5260
HMI Group and Siemens Healthineers enters into strategic partnership to advance healthcare delivery in Southeast Asia
* This 5-year partnership valued over SGD 32 million, is first-of-its-kind strategic partnership for Siemens Healthineers in the region. * It focuses on upgrading HMI Group's healthcare facilities, anchoring on digitalization and enhancing local talent pool. * It includes further developme...
2021-04-28 08:05
3473
Varian and Icon Group Partner to Extend Commitment to Global Cancer Care
PALO ALTO, Calif., April 28, 2021 /PRNewswire/ -- Varian (NYSE: VAR), a Siemens Healthineers company, has signed an agreement withAustralia's Icon Group to provide 30 linear accelerators and associated treatment software to help tackle the growing global cancer burden. This agreement further stre...
2021-04-28 04:15
2651
HOYA Vision Care Releases Results of Three-Year MiYOSMART Spectacle Lens Follow-up Study
Strong evidence shows continued lens effectiveness in slowing myopia progression in children in third year BANGKOK, April 27, 2021 /PRNewswire/ -- HOYA Vision Care, a leader in optical technology innovation, shared the results of a three-year follow-up clinical study on its award winning MiYOS...
2021-04-27 21:33
3217
Rare Brain Damaged Patient May Settle Controversy Over Fish Pain
Scientists have examined rare brain damaged patients and found key areas of the brain thought to be needed for pain are not in fact necessary, undercutting a key argument used to deny pain in fish. ARLINGTON, Texas, April 27, 2021 /PRNewswire/ -- Taylor & Francis announces that a multidisciplina...
2021-04-27 20:00
1466
Holmusk Acquires Mental Health Analytics Provider Otsuka Health Solutions to Expand its Footprint in the UK
LONDON, April 27, 2021 /PRNewswire/ -- Holmusk, a leading global data science and digital health company building the world's largest Real-World Evidence (RWE) platform for behavioral health, announced today that it has acquired Otsuka Health Solutions (OHS), a UK-based mental health, predictive ...
2021-04-27 14:00
2098
Bushu Pharma's Collaboration with Suzuken Group Expands Services for Specialty Pharmaceuticals
KAWAGOE, Japan, April 27, 2021 /PRNewswire/ -- -Establishment of New Business Alliance and Facility to Provide Comprehensive Support for New Product Launches for Manufacturers Aiming to Enter Japan Market- Bushu Pharmaceuticals Ltd. (hereinafter "Bushu Pharma") has entered into a business allian...
2021-04-27 14:00
2333
MSIG partners with Singapore Cancer Society to raise public awareness on cancer risks
* Through a range of virtual seminars jointly organised with Singapore Cancer Society, MSIG will be educating its stakeholders on the topic of cancer prevention * MSIG will donate $10 for every CancerCare Plus policy sold to support SCS' cancer programmes and patient care services SINGAPORE, ...
2021-04-27 10:00
3157
DiscGenics Completes Patient Enrollment in Japanese Clinical Study of Cell Therapy for Disc Degeneration as US Study Achieves One-Year Follow-up Milestone
SALT LAKE CITY and TOKYO, April 27, 2021 /PRNewswire/ -- DiscGenics, Inc., a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced that it has c...
2021-04-27 09:23
2668
Himalaya Therapeutics Announces Appointment of Brian Zhang as Chief Executive Officer
SAN DIEGO, April 26, 2021 /PRNewswire/ -- Himalaya Therapeutics ("Himalaya"), a clinical-stage biopharmaceutical company focused on development and commercialization inGreater China of a novel class of investigational antibody therapeutics for the treatment of solid tumor cancer, which are based ...
2021-04-26 22:08
3820
CStone Announces NMPA Acceptance of New Drug Application of Selective Inhibitor GAVRETO(R) (Pralsetinib) with Priority Review Designation for the Treatment of Advanced or Metastatic RET-Altered Thyroid Cancer Patients
SUZHOU, China, April 26, 2021 /PRNewswire/ -- CStone Pharmaceuticals (CStone, HKEX: 2616), a leading biopharmaceutical company focused on developing and commercializing innovative immuno-oncology therapies and precision medicines, today announces that the National Medical Products Administration ...
2021-04-26 21:14
4242
PharmAbcine to Present at the Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual Meeting
DAEJEON, South Korea, April 26, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of antibody therapeutics, announced today that the company will present an e-poster featuring non-clinical data of PMC-403 at the Association for ...
2021-04-26 20:00
1869
Week's Top Stories
Most Reposted
ABL Bio Receives Upfront Payment for License, Research and Collaboration Agreement for Grabody Platform and Equity Investment from Lilly
[Picked up by 278 media titles]
2025-12-26 12:55ACEN completes transition to 100% renewable energy
[Picked up by 273 media titles]
2025-12-29 18:53Vietnam's Newest EDM Destination, APLUS SAIGON, Debuts With Star-Studded Soft Opening Weekends Featuring Dombresky and Argy
[Picked up by 273 media titles]
2025-12-30 20:12
CYFIRMA's 2025 Impact Recap Showcases DeCYFIR, Preemptive External Threat Landscape Management Platform, Delivering Measurable Global Defense Against Emerging Threats
[Picked up by 262 media titles]
2025-12-29 09:00
ChinaAMC launches Depository Receipts of two Chinese flagship ETFs in Thai exchange
[Picked up by 259 media titles]
2025-12-29 14:27